Abstract:Ulcerative colitis patients have an increased risk of developing colorectal cancer (CRC). The aim of the current study was to determine whether Emu Oil (EO) could reduce the severity of colitis, thereby inhibiting colitis-associated CRC (CA-CRC) development. Female C57BL/6 mice (n = 8/group) were injected (i.p.) with saline or azoxymethane (AOM) (7.4 mg/kg). Mice underwent three dextran sulfate sodium (DSS)/water cycles. Mice were orally-administered either water (160 µL) or EO (80 µL or 160 µL) thrice weekly and euthanized after 12 weeks. AOM/DSS decreased bodyweight compared with normal controls (max. 20%; p < 0.05). In AOM/DSS mice, EO (160 µL) increased bodyweight compared with untreated and 80 µL EO-treated mice (max. 10%; p < 0.05). Both volumes of EO reduced disease activity index (DAI) scores on day 49, 56–63 (max. 40%; p < 0.05), compared with AOM/DSS controls. Histological damage was increased in the distal colon of AOM/DSS mice, and reduced by EO (160 µL; p < 0.05). Mucin-secreting goblet cells were increased by AOM/DSS compared to normal, with no effect observed following EO treatment (p > 0.05). Large tumor numbers were decreased in EO-treated mice (160 µL; 2 ± 0.6) compared with AOM/DSS controls (5 ± 0.7; p < 0.05). EO did not impact overall tumor number (p > 0.05). Other analyses remained unchanged across groups (p > 0.05). EO demonstrates promise as an adjunct to conventional treatment options for colitis management.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether emu oil (EO) can reduce the severity of colitis and inhibit the development of colitis - associated colorectal cancer (CA - CRC). Specifically, the study aims to evaluate the effects of different doses of emu oil on the following aspects by using a mouse model: 1. **Body weight change**: Evaluate whether emu oil can reduce the body weight loss caused by AOM/DSS. 2. **Disease Activity Index (DAI)**: Evaluate whether emu oil can reduce the DAI score, thereby alleviating clinical symptoms. 3. **Histopathological damage**: Evaluate whether emu oil can reduce the histopathological damage in the distal colon. 4. **Number and size of tumors**: Evaluate whether emu oil can reduce the number of colon tumors, especially the number of large tumors. ### Research background Patients with ulcerative colitis (UC) have a relatively high risk of developing colorectal cancer (CRC). Although current treatment methods have certain effects in inducing and maintaining remission, a considerable proportion of patients still cannot maintain the remission state for a long time. Therefore, finding new adjuvant treatment methods, such as natural substances with anti - inflammatory and antioxidant properties, is of great significance for managing UC and preventing CA - CRC. ### Research methods The study used female C57BL/6 mice and divided them into four experimental groups: 1. Normal control group (Saline + Water + Water) 2. CA - CRC control group (AOM + DSS + Water) 3. Low - dose emu oil group (AOM + DSS + Emu Oil 80 mL) 4. High - dose emu oil group (AOM + DSS + Emu Oil 160 mL) Mice received AOM injection on day 0, followed by three DSS water cycles. During the entire experimental period, water or different doses of emu oil were administered three times a week by oral gavage. After the experiment lasted for 12 weeks, the mice were euthanized and relevant data were collected. ### Main results 1. **Body weight change**: The body weight of mice treated with AOM/DSS decreased significantly, while high - dose emu oil (160 mL) could significantly increase the body weight of these mice. 2. **Disease Activity Index (DAI)**: The DAI score of mice treated with AOM/DSS increased significantly, while high - dose emu oil (160 mL) could significantly reduce the DAI score. 3. **Histopathological damage**: The histopathological damage in the distal colon of mice treated with AOM/DSS increased significantly, while high - dose emu oil (160 mL) could significantly reduce this damage. 4. **Number and size of tumors**: A large number of tumors appeared in the colon of mice treated with AOM/DSS, while high - dose emu oil (160 mL) could significantly reduce the number of large tumors, but had no significant effect on the total number of tumors. ### Conclusion The research results show that high - dose emu oil (160 mL) shows significant therapeutic effects in reducing the severity of colitis and inhibiting the development of large colon tumors. This suggests that emu oil may become an effective adjuvant treatment method for managing colitis and preventing CA - CRC. Future research can further explore the mechanism of action of emu oil and its application potential in other related diseases.

Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer

Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer

Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats

Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis

Eicosapentaenoic Acid and Docosahexaenoic Acid Suppress Colonic Tumorigenesis in Obese Mice

Camel milk Whey Inhibits Inflammatory Colorectal Cancer Development Via Down regulation of Pro-inflammatory Cytokines in Induced AOM/DSS Mouse Model

Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis

Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development

Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer

Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer

EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS

Inhibitory Effect of a Microecological Preparation on Azoxymethane/Dextran Sodium Sulfate-Induced Inflammatory Colorectal Cancer in Mice

Sex differences in inflammation correlated with estrogen and estrogen receptor-β levels in azoxymethane/dextran sodium sulfate-induced colitis-associated colorectal cancer mice

Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis

Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity

Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice

Lacticaseibacillus rhamnosus LS8 Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Tumorigenesis in Mice via Regulating Gut Microbiota and Inhibiting Inflammation

Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis Through Its Anti-Inflammation Effects in Mice.

miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition

Therapeutic Potential and Deleterious Effect of Glucocorticoids on Azoxymethane/dextran Sulfate Sodium-Induced Colorectal Cancer in Mice.

Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model